fda pulls semaglutide 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Hims launched an oral semaglutide

retatrutide, a weight-loss drug that is in late clinical trials but is already being seen by medical experts as the next big leap in the treatment of diabetes and obesity

Its reconstitution process is mechanically the same, but the doses are measured in micrograms (mcg) rather than milligrams (mg)

Eating a standard sized dinner on top of that is a recipe for nausea, bloating, and discomfort

[2] Centrally, these medications act on appetite-regulating centres in the hypothalamus, leading to reduced caloric intake and subsequent weight loss

Starting with a lower microdose can reduce the likelihood of severe early nausea, and taking your injection in the evening may allow you to sleep through the worst of any discomfort